CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-01 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −9,416 | 162,025 | ||
| 2021-02-08 | Lucchino David L. President and CEO | Exercise or conversion | +16,554 | $0.61 | $10K | 324,640 |
| 2021-02-08 | Lucchino David L. President and CEO | Sale | −5,518 | $52.50 | $290K | 319,122 |
| 2021-02-08 | Lucchino David L. President and CEO | Sale | −5,518 | $55.00 | $303K | 313,604 |
| 2021-02-08 | Lucchino David L. President and CEO | Sale | −5,518 | $57.50 | $317K | 308,086 |
| 2021-02-08 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −16,554 | 171,441 | ||
| 2021-02-03 | Lucchino David L. President and CEO | Exercise or conversion | +11,036 | $0.61 | $7K | 319,122 |
| 2021-02-03 | Lucchino David L. President and CEO | Sale | −5,518 | $47.50 | $262K | 313,604 |
| 2021-02-03 | Lucchino David L. President and CEO | Sale | −5,518 | $50.00 | $276K | 308,086 |
| 2021-02-03 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −11,036 | 187,995 | ||
| 2021-02-03 | Loose Christopher R. Chief Scientific Officer | Sale | −2,000 | $47.19 | $94K | 21,782 |
| 2021-02-02 | Lucchino David L. President and CEO | Exercise or conversion | +5,518 | $0.61 | $3K | 313,604 |
| 2021-02-02 | Lucchino David L. President and CEO | Sale | −3,800 | $45.76 | $174K | 309,804 |
| 2021-02-02 | Lucchino David L. President and CEO | Sale | −1,709 | $46.84 | $80K | 308,095 |
| 2021-02-02 | Lucchino David L. President and CEO | Sale | −9 | $47.36 | $426 | 308,086 |
| 2021-02-02 | Lucchino David L. President and CEO | Exercise or conversion · Stock Option | −5,518 | 199,031 | ||
| 2021-02-02 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $45.02 | $360K | 23,782 |
| 2021-02-01 | Lucchino David L. President and CEO | Exercise or conversion | +33,102 | $0.61 | $20K | 341,188 |
| 2021-02-01 | Lucchino David L. President and CEO | Sale | −2,900 | $41.29 | $120K | 338,288 |
| 2021-02-01 | Lucchino David L. President and CEO | Sale | −18,600 | $42.85 | $797K | 319,688 |
Page 24 of 34 · 670 trades